Carol Berry
Direttore/Membro del Consiglio presso Venn Biosciences Corp.
Profilo
Carol E.
Berry is currently the Director at Venn Biosciences Corp.
and also holds the position of Chief Business Officer & Senior Vice President at CellCarta Biosciences, Inc. Previously, she worked as the Head-Sales & Marketing at Aspira Women's Health, Inc. from 2002 to 2007.
She also served as the Senior Vice President & General Manager at Asuragen, Inc. and as the Principal at Roche Biomedical Laboratories, Inc. Additionally, she held the position of Vice President-Sales & Marketing at Dynacare Laboratories LP.
Ms. Berry completed her undergraduate degree from Texas A&M University and earned an MBA from the University of Dallas in 2004.
Posizioni attive di Carol Berry
| Società | Posizione | Inizio |
|---|---|---|
Venn Biosciences Corp.
 Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | 04/10/2022 |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Precedenti posizioni note di Carol Berry
| Società | Posizione | Fine |
|---|---|---|
| ASPIRA WOMEN'S HEALTH INC. | Vendite & Marketing | - |
Dynacare Laboratories LP
 Dynacare Laboratories LP Medical/Nursing ServicesHealth Services Dynacare Laboratories engages in the provision of medical diagnostic laboratory services. It also offers esoteric and routine testing including cytogenetic and toxicology. The company is headquartered in Seattle, WA. | Vendite & Marketing | - |
| Roche Biomedical Laboratories, Inc. | Corporate Officer/Principal | - |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Corporate Officer/Principal | - |
Formazione di Carol Berry
| Texas A&M University | Undergraduate Degree |
| University of Dallas | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
| Roche Biomedical Laboratories, Inc. | Health Technology |
Dynacare Laboratories LP
Dynacare Laboratories LP Medical/Nursing ServicesHealth Services Dynacare Laboratories engages in the provision of medical diagnostic laboratory services. It also offers esoteric and routine testing including cytogenetic and toxicology. The company is headquartered in Seattle, WA. | Health Services |
Venn Biosciences Corp.
Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | Health Technology |
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
- Borsa valori
- Insiders
- Carol Berry
